Balance Sheet
Accumulated ExpensesAssetsCash & EquivalentsCurrent AssetsCurrent Deferred RevenueFinished GoodsInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current Deffered RevenueNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

HUTCHMED (China) (HCM) Other Accumulated Expenses: 2015-2024

Historic Other Accumulated Expenses for HUTCHMED (China) (HCM) over the last 10 years, with Dec 2024 value amounting to $12.5 million.

  • HUTCHMED (China)'s Other Accumulated Expenses fell 15.45% to $5.1 million in Q2 2025 from the same period last year, while for Jun 2025 it was $5.1 million, marking a year-over-year decrease of 15.45%. This contributed to the annual value of $12.5 million for FY2024, which is 19.09% up from last year.
  • As of FY2024, HUTCHMED (China)'s Other Accumulated Expenses stood at $12.5 million, which was up 19.09% from $10.5 million recorded in FY2023.
  • In the past 5 years, HUTCHMED (China)'s Other Accumulated Expenses ranged from a high of $17.2 million in FY2021 and a low of $5.6 million during FY2020.
  • For the 3-year period, HUTCHMED (China)'s Other Accumulated Expenses averaged around $11.7 million, with its median value being $12.2 million (2022).
  • As far as peak fluctuations go, HUTCHMED (China)'s Other Accumulated Expenses soared by 205.94% in 2021, and later dropped by 28.97% in 2022.
  • Over the past 5 years, HUTCHMED (China)'s Other Accumulated Expenses (Yearly) stood at $5.6 million in 2020, then skyrocketed by 205.94% to $17.2 million in 2021, then declined by 28.97% to $12.2 million in 2022, then declined by 14.20% to $10.5 million in 2023, then increased by 19.09% to $12.5 million in 2024.